Pharsight

Pohl Boskamp patents expiration

1. Gonitro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9101592 POHL BOSKAMP Stabilized granules containing glyceryl trinitrate
Mar, 2032

(8 years from now)

Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 08 June, 2016

Treatment: NA

Dosage: POWDER;SUBLINGUAL

More Information on Dosage

GONITRO family patents

Family Patents

2. Nitrolingual patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7872049 POHL BOSKAMP Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
Mar, 2029

(5 years from now)

Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 31 October, 1985

Treatment: Method of treating angina pectoris

Dosage: SPRAY, METERED;SUBLINGUAL

How can I launch a generic of NITROLINGUAL before it's drug patent expiration?
More Information on Dosage

NITROLINGUAL family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic